Peptide compound and its preparation
AssigneeFujisawa Pharmaceutical Co., Ltd.
InventorsKeiji Hemmi, Masahiro Neya, Naoki Fukami, Masashi Hashimoto, Hirokazu Tanaka, Natsuko Kayakiri
Life of this patent
Estimating the term…
Loading patent…
AssigneeFujisawa Pharmaceutical Co., Ltd.
InventorsKeiji Hemmi, Masahiro Neya, Naoki Fukami, Masashi Hashimoto, Hirokazu Tanaka, Natsuko Kayakiri
Estimating the term…
Peptide compounds of the formula (I') ##STR1## in which R.sup.1 is acyl, R.sup.2 is lower alkyl, cyclo(lower)alkyl(lower)alkyl or optionally substituted heterocyclic(lower)alkyl, R.sup.3 is optionally substituted heterocyclic(lower)alkyl or optionally substituted ar(lower)alkyl, R.sup.4 is lower alkyl, amino(lower)alkyl, protected amino(lower)alkyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl or optionally substituted heterocyclic(lower)alkyl, R.sup.5 is carboxy, protected carboxy, carboxy(lower)alkyl or protected carboxy(lower)alkyl, R.sup.6 is hydrogen, lower alkyl, C.sub.6-10 ar(lower)alkyl amino(lower)alkyl, protected amino(lower)alkyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl, or heterocyclic(lower)alkyl, R.sup.7 is hydrogen or lower alkyl, and A is --O--, --NH--, lower alkylimino or lower alkylene, or a pharmaceutically acceptable salt thereof are disclosed. The compounds can be used to treat and prevent endothelin mediated diseases such as hypertension. The preparation of such peptides is also disclosed.
A peptide compound having the formula (I') ##STR10## or a pharmaceutically acceptable salt thereof in which R.sup.1 is acyl,
A process for the preparation of a peptide compound having the formula (I') ##STR11## or a pharmaceutically acceptable salt thereof in which R.sup.2 is acyl,
Dependencies are inferred from the claim text.